Synapticure

We deliver personalized medicine for neurodegenerative patients

Y CombinatorSummer 2020ActiveHealthcareHealthcare ServicesHealth TechTelehealthDigital HealthHealthcare

What they do

Problem

Neurodegenerative disease patients and caregivers struggle to access coordinated, personalized multidisciplinary care, referrals, and support services.

Solution

Synapticure provides personalized virtual clinical care with a dedicated care coordinator who organizes multidisciplinary resources, referrals, trials, prescriptions, and home health/PT/OT support.

Who it's for

Neurodegenerative disease patients and their caregivers seeking ongoing coordinated clinical care and support.

Founders

Peter Wallach

Founding CEO, Founder

Founder / Founding CEO, SynaptiCure Inc. Eternal optimist. Recovering Bain consultant and avid baseball fan.

LinkedIn · X

Brian Wallach

Founder

Brian Wallach is an attorney and ALS patient. In the aftermath of his diagnosis in November 2017, he and his wife founded I AM ALS, a patient-led, patient-centric movement to lead the fight for a cure to the disease. Wallach is also an associate at the law firm Skadden, Arps, Slate, Meagher & Flom LLP. From 2014 to 2018, he served as an assistant United States attorney in the Northern District of Illinois. From 2011 to 2013, he was senior vetting counsel in the Obama White House.

LinkedIn · X

Martina de Majo

Founder

Martina is the director of research and development at Synapticure and she focuses on creating iPSC derived in vitro models to study neurodegenerative disorders. Martina received an undergraduate degree in biotechnology and a Master's degree in pharmaceutical biotechnology from the University of Rome "La Sapienza" (Italy), she then earned a PhD in clinical neuroscience from King's College London (UK) and deepened her knowledge of iPSC derived modelling in her postdoc at UCSF (US)

LinkedIn · X